Audit 29965

FY End
2022-12-31
Total Expended
$3.16M
Findings
0
Programs
7
Year: 2022 Accepted: 2023-07-13

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
93.172 Human Genome Research $677,278 Yes 0
93.855 Allergy, Immunology and Transplantation Research $522,412 Yes 0
93.310 Trans-Nih Research Support $432,575 Yes 0
93.396 Cancer Biology Research $133,470 Yes 0
47.049 Mathematical and Physical Sciences $70,398 Yes 0
47.074 Biological Sciences $50,291 Yes 0
93.859 Biomedical Research and Research Training $39,232 Yes 0

Contacts

Name Title Type
GX1TUDQ8F9M5 Linda Jackson Auditee
3864188085 Ross Burden Auditor
No contacts on file

Notes to SEFA

Title: Note 3-Noncash awards Accounting Policies: The accompanying schedule of expenditures of federal awards (the "Schedule") includes the federal award activity of the Foundation for Applied Molecular Evolution, Inc. (the "Foundation") under programs of the federal government for the year ended December 31, 2022. The information in the Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations (CFR) Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards ("Uniform Guidance"). Because the Schedule presents only a selected portion of the operations of the Foundation, it is not intended to and does not present the financial position, changes in net assets, or cash flows of the Foundation. De Minimis Rate Used: N Rate Explanation: The Foundation expended indirect costs using a multiple allocation base method and did not elect to use the 10% de minimis cost rate allowed under the Uniform Guidance. The Foundation did not receive noncash federal awards during the year ended December 31, 2022.
Title: Note 4-Contingencies Accounting Policies: The accompanying schedule of expenditures of federal awards (the "Schedule") includes the federal award activity of the Foundation for Applied Molecular Evolution, Inc. (the "Foundation") under programs of the federal government for the year ended December 31, 2022. The information in the Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations (CFR) Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards ("Uniform Guidance"). Because the Schedule presents only a selected portion of the operations of the Foundation, it is not intended to and does not present the financial position, changes in net assets, or cash flows of the Foundation. De Minimis Rate Used: N Rate Explanation: The Foundation expended indirect costs using a multiple allocation base method and did not elect to use the 10% de minimis cost rate allowed under the Uniform Guidance. These programs are subject to financial and compliance audits by grantor agencies. The amount, if any, of expenditures that may be disallowed by the grantor agencies cannot be determined at this time, although the Foundation expects such amounts, if any, to be immaterial.